Abstract
The antiapoptotic protein Bcl-2 is overexpressed in human cancers, and confers resistance to antitumor agents in cancer cells. Bcl-2 is negatively regulated by the tumor suppressor p53 in response to DNA damage during apoptotic cell death. However, this molecular mechanism remains unclear. The available evidence indicates that miR-1915 represses Bcl-2 expression at the post-transcriptional level in human colorectal carcinoma cells, which is correlated with drug resistance. Here, we show that p53 controls miR-1915 expression in response to DNA damage. Induction of p53 affects the expression of precursor and mature, but not primary, miR-1915. Inhibition of miR-1915 abrogates downregulation of Bcl-2 expression following treatment with genotoxin. These findings demonstrate that p53 negatively regulates Bcl-2 expression by targeting miR-1915 processing from primary into precursor miRNA. Taken together, the findings of the current study reveal a novel mechanism whereby p53 negatively modulates Bcl-2 by controlling miR-1915. Bcl-2 is overexpressed in cancers and is negatively regulated by p53 during apoptotic cell death. However, this molecular mechanism remains unclear. Here we show that p53 controls miR-1915 expression. p53 affects the precursor and mature, but not primary, miR-1915. The inhibition of miR-1915 abrogates downregulation of Bcl-2 expression following genotoxin. These findings demonstrate that p53 modulates Bcl-2 by controlling miR-1915. © 2014 FEBS.
Author supplied keywords
Cite
CITATION STYLE
Nakazawa, K., Dashzeveg, N., & Yoshida, K. (2014). Tumor suppressor p53 induces miR-1915 processing to inhibit Bcl-2 in the apoptotic response to DNA damage. FEBS Journal, 281(13), 2937–2944. https://doi.org/10.1111/febs.12831
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.